Bayer Pharmaceuticals Corporation (CT)
400 Morgan Lane
West Haven
Connecticut
06516
United States
Tel: 203-812-2000 or 800-468-0894
Fax: 203-812-3188
Website: http://www.bayerpharma-na.com/
40 articles about Bayer Pharmaceuticals Corporation (CT)
-
Bayer's Shirell A. Gross Recognized as One of Savoy Magazine's 2018 Most Influential Black Lawyers
7/9/2018
Shirell A. Gross, Esq., Vice-President and Head of Law for Bayer Pharmaceuticals, Radiology, has been recognized by Savoy Magazine as one of their 2018 Most Influential Black Lawyers.
-
Piramal Healthcare Limited Nabs Bayer Pharmaceuticals Corporation (CT)'s Molecular Imaging Development Portfolio for Undisclosed Amount
4/16/2012
-
Previous Merck & Co., Inc. and Bayer Pharmaceuticals Corporation (CT) Executive Accepts Full Time Role and Company Adds More Experience to Fuse Science Management Team
2/16/2012
-
Oculus Innovative Sciences, Inc. Announces Agreement with Bayer Australia Limited for Development of Microcyn(R) Technology Use in Australian Animal Market
6/19/2008
-
Bayer Pharmaceuticals Corporation (CT)'s Erectile Dysfunction Drug Levitra to Get Label Change Noting Rare Reports of Transient Global Amnesia
5/30/2008
-
DARA BioSciences, Inc. and Bayer Pharmaceuticals Corporation (CT) Sign Exclusive License Agreement
10/17/2007
-
Bayer Pharmaceuticals Corporation (CT)/Onyx Pharmaceuticals, Inc. Report Success in Asian Trial for Nexavar
8/30/2007
-
Onyx Pharmaceuticals, Inc. Doubles On Positive Nexavar News
2/12/2007
-
Bayer Pharmaceuticals Corporation (CT) Searches For Hemophilia Leadership Development Program Intern
1/24/2007
-
Bayer Pharmaceuticals Corporation (CT) Extends License To Linguamatics And BioWisdom For Text Search And Mining
12/20/2006
-
Bayer Pharmaceuticals Corporation (CT) Informs Health Care Professionals Of Important Safety Revisions To The Trasylol Label
12/18/2006
-
The Day In Review: Shire Pharmaceuticals Wins Elaprase Approval
7/24/2006
-
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. Release: Nexavar(R) Approved By European Commission For The Treatment Of Advanced Kidney Cancer
7/24/2006
-
CuraGen Corporation Announces Changes To Metabolic Disease Collaboration For The Development Of BAY 76-7171
7/20/2006
-
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc.'s Nexavar Receives FDA Fast Track Designation For Skin Cancer
7/20/2006
-
Pfizer Inc. Enters Into Agreement With Bayer Pharmaceuticals Corporation (CT) To License Compounds For Potential Treatment Of Obesity, Diabetes And Related Disorders
6/14/2006
-
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. Release: Nexavar Receives Fast Track Designation From The FDA For Metastatic Liver Cancer
6/13/2006
-
Bayer Pharmaceuticals Corporation (CT) Release: Updated Overall Survival Analysis Presented On Nexavar Phase III Trial
6/5/2006
-
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. Kidney Cancer Drug Nexavar Misses Survival Goal In Trial
6/5/2006
-
Bayer HealthCare AG, The National Hemophilia Foundation, And Andretti Green Racing Announce Racing For Hemophilia Primary Donor For The 2006 Indianapolis 500
5/25/2006